Cite
MLA Citation
Seung Tae Kim et al.. “Oxaliplatin (3 months v 6 months) With 6 Months of Fluoropyrimidine as Adjuvant Therapy in Patients With Stage II/III Colon Cancer: KCSG CO09-07.” Journal of clinical oncology, vol. 40, no. 33, 2022, pp. 3868–3877. http://access.bl.uk/ark:/81055/vdc_100169740683.0x00001f